Nicole Bundy, MD, MPH, discusses the need for lifestyle interventions, in addition to pharmacologic treatment, during the management of patients with autoimmune diseases.
Michael C. Schweitz, MD, discusses how a South Florida arthritis clinic, which provides care to vulnerable patients with rheumatologic conditions, was saved from closing with the help of CreakyJoints.
Huy D. Dang, DPM, recounts his personal experience of living with gout and currently treating patients with the same condition.
In this perspective, S. Louis Bridges Jr, MD, PhD, provides insight into managing care for patients with rheumatic diseases during the COVID-19 pandemic.
In this perspective, Tracy M. Frech, MD, MS, discusses the diagnosis and management of systemic sclerosis.
John K Botson, MD, discusses how clinicians in the rheumatology space can adjust their approach to patient care during the COVID-19 pandemic.
Effective and affordable treatment options are essential to controlling costs within the rheumatoid arthritis treatment space and delivering value to patients.
If physicians have a genuine interest in acting with beneficence and nonmaleficence, they should recognize that their prescribing habits have significant consequences for their patients.
During the last decade, the number of medical students choosing internal or family medicine has dropped by approximately 80%.
The utility and effectiveness of wearable fitness devices are discussed in a clinician’s opinion piece.
Practice managers can either be beneficial to a practice, or add unneeded stress.
Medical overuse can be reduced by involving patients in shared-decision making.
Independent physicians need to stop fighting the system.
The practices in healthcare today need to be reevaluated.
Clear communication between patients and caregivers with regard to treatment futility or the perception of treatment futility is important.